Literature DB >> 19196927

Depression in schizophrenia: methodological artifact or distinct feature of the illness?

Eran Chemerinski1, Christopher Bowie, Hannah Anderson, Philip D Harvey.   

Abstract

In schizophrenia, there is a conceptual overlap between depressive and negative symptoms. This study examined the dimensional structure of depressive symptoms and their overlap with negative symptoms in a large sample of older medicated schizophrenia outpatients. Self-reported depression was obtained with the Beck Depression Inventory-II (BDI-II). Three components from this scale (i.e., dysphoria, psychosomatic and regret domains) showed excellent factorability and good consistency. However, adequate construct validity and correlates with outcomes were found for the dysphoria and regret domains, but not for the total score or the psychosomatic domain. Thus, the evaluation of domains within the BDI-II provides a more pure and clinically-relevant assessment of depressed mood in schizophrenia than the use of this scale as a whole.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19196927      PMCID: PMC2668194          DOI: 10.1176/jnp.2008.20.4.431

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  52 in total

1.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

2.  Depressive symptom patterns in patients with chronic schizophrenia and subsyndromal depression.

Authors:  Sidney Zisook; Maren Nyer; John Kasckow; Shah Golshan; David Lehman; Lori Montross
Journal:  Schizophr Res       Date:  2006-06-05       Impact factor: 4.939

3.  The clinical significance of subsyndromal depression in older primary care patients.

Authors:  Jeffrey M Lyness; JaeHyun Kim; Wan Tang; Xin Tu; Yeates Conwell; Deborah A King; Eric D Caine
Journal:  Am J Geriatr Psychiatry       Date:  2007-01-09       Impact factor: 4.105

4.  Factor Structure of the Beck Depression Inventory-II in patients With chronic pain.

Authors:  Helen Poole; Ros Bramwell; Peter Murphy
Journal:  Clin J Pain       Date:  2006 Nov-Dec       Impact factor: 3.442

5.  The validity of Beck Depression Inventory and Hamilton Rating Scale for Depression items in the assessment of depression among patients with multiple sclerosis.

Authors:  Patricia J Moran; David C Mohr
Journal:  J Behav Med       Date:  2005-02

6.  Reliability and validity of the Beck depression inventory in patients with Parkinson's disease.

Authors:  Martine Visser; Albert F G Leentjens; Johan Marinus; Anne M Stiggelbout; Jacobus J van Hilten
Journal:  Mov Disord       Date:  2006-05       Impact factor: 10.338

7.  Psychiatric comorbidity in first episode schizophrenia: a 2 year, longitudinal outcome study.

Authors:  Kang Sim; Thiam Hee Chua; Yiong Huak Chan; Rathi Mahendran; Siow Ann Chong
Journal:  J Psychiatr Res       Date:  2006-08-14       Impact factor: 4.791

Review 8.  Direct assessment of functional abilities: relevance to persons with schizophrenia.

Authors:  Christine L McKibbin; John S Brekke; Danielle Sires; Dilip V Jeste; Thomas L Patterson
Journal:  Schizophr Res       Date:  2004-12-15       Impact factor: 4.939

9.  Does cognition predict community function only in schizophrenia?: a study of schizophrenia patients, bipolar affective disorder patients, and community control subjects.

Authors:  JoAn R Laes; Scott R Sponheim
Journal:  Schizophr Res       Date:  2006-01-27       Impact factor: 4.939

10.  Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms.

Authors:  Christopher R Bowie; Abraham Reichenberg; Thomas L Patterson; Robert K Heaton; Philip D Harvey
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

View more
  15 in total

1.  Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder.

Authors:  Christopher R Bowie; Colin Depp; John A McGrath; Paula Wolyniec; Brent T Mausbach; Mary H Thornquist; James Luke; Thomas L Patterson; Philip D Harvey; Ann E Pulver
Journal:  Am J Psychiatry       Date:  2010-05-17       Impact factor: 18.112

2.  Individualized differential diagnosis of schizophrenia and mood disorders using neuroanatomical biomarkers.

Authors:  Nikolaos Koutsouleris; Eva M Meisenzahl; Stefan Borgwardt; Anita Riecher-Rössler; Thomas Frodl; Joseph Kambeitz; Yanis Köhler; Peter Falkai; Hans-Jürgen Möller; Maximilian Reiser; Christos Davatzikos
Journal:  Brain       Date:  2015-05-01       Impact factor: 13.501

3.  Negative symptoms and their association with depressive symptoms in the long-term course of schizophrenia.

Authors:  Wolfram An der Heiden; Anne Leber; Heinz Häfner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-04-23       Impact factor: 5.270

4.  Predictors of the accuracy of self assessment of everyday functioning in people with schizophrenia.

Authors:  Samir Sabbag; Elizabeth W Twamley; Lea Vella; Robert K Heaton; Thomas L Patterson; Philip D Harvey
Journal:  Schizophr Res       Date:  2012-03-02       Impact factor: 4.939

5.  Insight, self-stigma and psychosocial outcomes in Schizophrenia: a structural equation modelling approach.

Authors:  Y-J Lien; H-A Chang; Y-C Kao; N-S Tzeng; C-W Lu; C-H Loh
Journal:  Epidemiol Psychiatr Sci       Date:  2016-12-15       Impact factor: 6.892

6.  Identification of targeted analyte clusters for studies of schizophrenia.

Authors:  Tammy M K Cheng; Yu-En Lu; Paul C Guest; Hassan Rahmoune; Laura W Harris; Lan Wang; Dan Ma; Victoria Stelzhammer; Yagnesh Umrania; Matt T Wayland; Pietro Lió; Sabine Bahn
Journal:  Mol Cell Proteomics       Date:  2009-12-10       Impact factor: 5.911

7.  Relationship between depressive symptoms and quality of life in Nigerian patients with schizophrenia.

Authors:  Adesanmi Akinsulore; Olutayo O Aloba; B M Mapayi; I O Oloniniyi; F O Fatoye; R O A Makanjuola
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-02-19       Impact factor: 4.328

8.  Assessment of trait and state aspects of depression in schizophrenia.

Authors:  Joshua Chiappelli; Katie L Nugent; Kavita Thangavelu; Katherine Searcy; L Elliot Hong
Journal:  Schizophr Bull       Date:  2013-05-17       Impact factor: 9.306

9.  Factor Structure, Convergent, and Divergent Validity of the Prodromal Questionnaire-Negative Symptom Subscale.

Authors:  Katherine M Pierce; Seth D Maxwell; Thomas M Olino; Shanna Cooper; Lauren M Ellman
Journal:  Assessment       Date:  2020-01-19

Review 10.  Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review.

Authors:  Noelle E Carlozzi; Angela Miciura; Nicholas Migliore; Praveen Dayalu
Journal:  J Huntingtons Dis       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.